Position in AZN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$602,541,630
+$189,583,463 QoQ
Shares Held
3,177,627
+51.8% QoQ
Ownership
0.205%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#51
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Boston Partners holds $3,635,506,449 across 12 Drug Manufacturers - General names. AZN ranks #3 (16.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
4,784,316 | $1,203,925,277 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
6,017,958 | $760,308,811 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
3,177,627 | $602,541,630 | |
| 4 | JNJ |
Johnson & Johnson
|
1,113,805 | $282,873,054 | |
| 5 | BIIB |
Biogen Inc.
|
1,263,429 | $272,976,467 | |
| 6 | AMGN |
Amgen Inc
|
637,923 | $231,004,675 | |
| 7 | SNY |
Sanofi
|
3,844,844 | $164,021,044 | |
| 8 | MRK |
Merck & Co., Inc.
|
629,240 | $80,857,340 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $602,541,630 | 3,177,627 | Shares | Other | 2026-08-04 | |
| 2026-03-31 | $412,958,167 | 2,093,896 | Shares | Defined | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||